Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction

Trends in Pharmacological Sciences

Volumn 27, Issue 12, 2006, Pages 612-618

  Rothman, Richard B ^a   Blough, Bruce E ^b   Baumann, Michael H ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 NAPTHYL 2 AMINOPROPANE; 3 FLUOROAMPHETAMINE; 4 METHYLAMPHETAMINE; AMPHETAMINE; BUPRENORPHINE; CHLORPHENTERMINE; COCAINE; DOPAMINE; FENFLURAMINE; METHADONE; NEUROTRANSMITTER; NICOTINE PATCH; NORADRENALIN; PAL 287; PHENTERMINE; PROPYLAMINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; UNCLASSIFIED DRUG;

AMINE TRANSPORT; ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOTOXICITY; CELL MEMBRANE; COCAINE DEPENDENCE; DEPRESSION; DOPAMINE RELEASE; DRUG DEPENDENCE; DRUG WITHDRAWAL; HUMAN; NEUROTOXICITY; NONHUMAN; OBESITY; OBSESSIVE COMPULSIVE DISORDER; OPIATE ADDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEROTONIN RELEASE; TOBACCO DEPENDENCE; VALVULAR HEART DISEASE;

ANIMALS; BRAIN; COCAINE-RELATED DISORDERS; DOPAMINE; HUMANS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS;

EID: 33750949917     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.10.006     Document Type: Article

References (62)

1. Rothman R.B., et al. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 (2001) 32-41
2. Volkow N.D., and Li T.K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 5 (2004) 963-970
3. Hyman S.E. Addiction: a disease of learning and memory. Am. J. Psychiatry 162 (2005) 1414-1422
4. Dackis C.A., and Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9 (1985) 469-477
5. Gawin F.H., and Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry 43 (1986) 107-113
6. Garlow S.J., et al. Cocaine use disorders and suicidal ideation. Drug Alcohol Depend. 70 (2003) 101-104
7. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 4 (2003) 819-828
8. Baumann M.H., and Rothman R.B. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans. Biol. Psychiatry 44 (1998) 578-591
9. Uhl G.R., and Johnson P.S. Neurotransmitter transporters: three important gene families for neuronal function. J. Exp. Biol. 196 (1994) 229-236
10. Rothman R.B., and Baumann M. Therapeutic and adverse actions of serotonin transporter substrates. Pharmacol. Ther. 95 (2002) 73-88
11. Koob G.F., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
12. Rothman R.B., et al. Combined use of fenfluramine and phentermine in the treatment of cocaine addiction: a pilot case series. J. Subst. Abuse Treat. 11 (1994) 273-275
13. Grabowski J., et al. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict. Behav. 29 (2004) 1439-1464
14. Roth B.L., et al. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3 (2004) 353-359
15. Parsons L.H., et al. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J. Pharmacol. Exp. Ther. 274 (1995) 1182-1191
16. Mateo Y., et al. Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharmacology 30 (2005) 1455-1463
17. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
18. Cunningham K.A., et al. Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding. Synapse 11 (1992) 112-123
19. Wilson J.M., et al. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14 (1994) 2966-2979
20. Mash D.C., et al. Dopamine transport function is elevated in cocaine users. J. Neurochem. 81 (2002) 292-300
21. Jacobsen L.K., et al. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am. J. Psychiatry 157 (2000) 1134-1140
22. Baumann M.H., et al. Evidence for alterations in presynaptic serotonergic function during withdrawal from cocaine in rats. Eur. J. Pharmacol. 282 (1995) 87-93
23. 1A agonist, 8-OH-DPAT. Neuropharmacology 33 (1994) 335-342
24. Haney M., et al. Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans. Drug Alcohol Depend. 64 (2001) 63-73
25. Ghitza, U.E. et al. Effects of cocaine self-administration on serotonergic responsiveness in human cocaine users. Drug Alcohol Depend. (in press)
26. Majewska M.D. HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 27 (2002) 5-12
27. Barr A.M., and Markou A. Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci. Biobehav. Rev. 29 (2005) 675-706
28. Walsh S.L., and Cunningham K.A. Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berl.) 130 (1997) 41-58
29. Barr A.M., et al. A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol. Sci. 23 (2002) 475-482
30. Wojnicki F.H.E., et al. Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food-presentation and cocaine-delivery in the rhesus monkey. J. Pharmacol. Exp. Ther. 288 (1999) 550-560
31. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl.) 167 (2003) 324-332
32. Rothman R.B., et al. Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann. N. Y. Acad. Sci. 965 (2002) 109-126
33. Glowa J.R., et al. Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. Neuroreport 8 (1997) 1347-1351
34. Glatz A.C., et al. Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine. Pharmacol. Biochem. Behav. 71 (2002) 197-204
35. Burmeister J.J., et al. Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats. Psychopharmacology (Berl.) 168 (2003) 146-154
36. Buydens-Branchey L., et al. Effect of fenfluramine challenge on cocaine craving in addicted male users. Am. J. Addict. 7 (1998) 142-155
37. Daw N.D., et al. Opponent interactions between serotonin and dopamine. Neural Netw. 15 (2002) 603-616
38. Burmeister J.J., et al. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 29 (2004) 660-668
39. Carroll M.E., et al. Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 35 (1990) 237-244
40. Howell L.L., and Byrd L.D. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J. Pharmacol. Exp. Ther. 275 (1995) 1551-1559
41. Roberts D.C., et al. Self-administration of cocaine analogs by rats. Psychopharmacology (Berl.) 144 (1999) 389-397
42. 2C receptors. Eur. J. Pharmacol. 480 (2003) 151-162
43. Baumann M.H., et al. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications. Synapse 36 (2000) 102-113
44. Rea W.P., et al. Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies. Synapse 30 (1998) 107-111
45. Brauer L.H., et al. Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Neuropsychopharmacology 14 (1996) 233-241
46. Connolly H.M., and McGoon M.D. Obesity drugs and the heart. Curr. Probl. Cardiol. 24 (1999) 745-792
47. 2B receptors in the cardiopathy associated with fenfluramine. Mol. Pharmacol. 57 (2000) 75-81
48. 2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102 (2000) 2836-2841
49. Setola V., et al. 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol. Pharmacol. 63 (2003) 1223-1229
50. Baumann M.H., et al. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain. Neuropsychopharmacology 24 (2001) 492-501
51. Nichols D.E., et al. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). J. Med. Chem. 33 (1990) 703-710
52. Rothman R.B., et al. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J. Pharmacol. Exp. Ther. 313 (2005) 1361-1369
53. 2C receptor mutant mice. Psychopharmacology (Berl.) 143 (1999) 309-314
54. Czoty P.W., et al. Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 300 (2002) 831-837
55. Negus, S.S. et al. Monoamine releasers with varying selectivity for dopamine vs serotonin release as candidate 'agonist' medications for cocaine dependence: studies in assays of cocaine discriminiation and cocaine self-administration in rhesus monkeys. J. Pharmacol. Exp. Ther. (in press)
56. Michelakis E.D., and Weir E.K. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Am. J. Med. Sci. 321 (2001) 292-299
57. Negus S.S., and Mello N.K. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend. 70 (2003) 39-52
58. Grabowski J., et al. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J. Clin. Psychopharmacol. 21 (2001) 522-526
59. Grabowski J., et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29 (2004) 969-981
60. Halladay A.K., et al. Alterations in alcohol consumption, withdrawal seizures, and monoamine transmission in rats treated with phentermine and 5-hydroxy-l-tryptophan. Synapse 59 (2006) 277-289
61. Wee S., et al. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J. Pharmacol. Exp. Ther. 313 (2005) 848-854
62. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40